Insider Trading April 7, 2026 04:22 PM

Andersons Director Disposes $1.1 Million in Shares as Company Posts Mixed Q4 Results

Patrick E. Bowe sells 15,000 shares; Andersons reports EPS beat, revenue shortfall and amends credit facility

By Nina Shah ANDE

Patrick E. Bowe, a director at Andersons, Inc., sold 15,000 shares on April 6, 2026, for $74.33 each, generating proceeds of $1,114,950. The transaction occurred with the stock trading near its 52-week high after a 104% one-year return. The company reported a fourth-quarter adjusted EPS beat but missed revenue expectations, and announced a reduction and extension to its revolving credit facility.

Andersons Director Disposes $1.1 Million in Shares as Company Posts Mixed Q4 Results
ANDE

Key Points

  • Director Patrick E. Bowe sold 15,000 shares on April 6, 2026 at $74.33 per share, totaling $1,114,950; he now directly owns 129,874.6324 shares.
  • Andersons reported adjusted Q4 EPS of $2.04, beating the $1.56 analyst expectation, while revenue of $2.54 billion missed the $3.28 billion projection.
  • The company amended its credit agreement, reducing the revolving facility from $1.55 billion to $1.30 billion and extending the maturity dates of the revolver and a $114.3 million term loan to March 20, 2031; Benchmark reaffirmed a Buy rating with a $75.00 target.

Andersons, Inc. (NASDAQ: ANDE) reported an insider transaction and a set of fourth-quarter financial and financing updates that together paint a mixed operational and capital picture.

On April 6, 2026, director Patrick E. Bowe sold 15,000 shares of the companys common stock at $74.33 per share, for total proceeds of $1,114,950. The sale took place while the shares were trading close to their 52-week high of $74.94, following a 104% return over the prior year.

Following the disposition, Bowe directly holds 129,874.6324 shares of Andersons. The transaction was carried out under a Limited Power of Attorney executed by Melissa Trippel.


Alongside the insider sale, Andersons released fourth-quarter results showing adjusted earnings per share of $2.04, exceeding analyst expectations of $1.56. Revenue for the period was $2.54 billion, which was short of the $3.28 billion consensus projection.

The company attributed its strong earnings performance primarily to its Renewables and Agribusiness segments. Renewables generated $54 million in pretax income, a result the company linked to record ethanol production. Agribusiness produced $46 million in pretax income amid what the company described as a record corn harvest.

In a financing update, Andersons said it had amended its credit agreement. The amendment reduced the capacity of the companys revolving credit facility from $1.55 billion to $1.30 billion and extended the facilitys maturity to March 20, 2031. The maturity date for the companys $114.3 million term loan was also extended to March 20, 2031.

Benchmark maintained a Buy rating on the company and left its price target at $75.00, citing the companys fourth-quarter strength. The firm highlighted operational tailwinds and 45Z tax credits as key contributors to the positive results.

The disclosed insider sale, the mixed top-line and bottom-line results, and the credit agreement amendment together provide a snapshot of recent developments at Andersons that investors and market observers may weigh against the shares recent performance near the 52-week high.

Risks

  • Revenue for the quarter fell short of analyst projections, highlighting potential volatility in top-line performance that could affect investor sentiment and market valuation.
  • The reduction in revolving credit capacity from $1.55 billion to $1.30 billion may constrain near-term liquidity or financial flexibility relative to prior commitments.
  • An insider sale occurred while shares traded near a 52-week high, which may introduce uncertainty among shareholders about insider timing; the sale was executed under a Limited Power of Attorney.

More from Insider Trading

Maplebear Director Ravi Gupta Offloads $7.5 Million Stake Amid Steady Operational Metrics Jun 4, 2026 United Therapeutics Executive Mahon Liquidates $4.54 Million Stake Under Pre-Arranged Plan Jun 4, 2026 Globalstar Executive Disposes of Shares Amidst Valuation Questions and Acquisition Speculation Jun 4, 2026 Oscar Health Executive Victoria Baltrus Liquidates Shares Under Pre-Arranged Plan Jun 4, 2026 Lincoln Educational Director Felecia Pryor Offloads $99,400 in Stock Jun 4, 2026